المؤلفون: Anastasiya F. Novikova, Larisa L. Popova, Dmitrii Yu. Konstantinov

المصدر: Инфекция и иммунитет, Vol 13, Iss 6, Pp 1141-1149 (2023)

مصطلحات موضوعية: chronic hepatitis b, cd4+ lymphocytes, tenofovir, antiviral therapy, recombinant interleukin-2, hbsag, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://iimmun.ru/iimm/article/viewFile/2063/1855Test; https://doaj.org/toc/2220-7619Test; https://doaj.org/toc/2313-7398Test

الوصول الحر: https://doaj.org/article/3d5f80df90e2485295c338355fc14928Test

المؤلفون: Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff, Richard Stratford, Trevor Clancy, Ludvig Andre Munthe

المصدر: Frontiers in Immunology, Vol 15 (2024)

مصطلحات موضوعية: T cell, COVID-19, CD8+ lymphocytes, CD4+ lymphocytes, vaccine, SARS-CoV-2, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1377041/fullTest; https://doaj.org/toc/1664-3224Test

الوصول الحر: https://doaj.org/article/71696a78c10c4e30a836d19c193d086eTest

المؤلفون: Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff, Richard Stratford, Trevor Clancy, Ludvig Andre Munthe

مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, T cell, COVID-19, CD8+ lymphocytes, CD4+ lymphocytes, vaccine, SARS-CoV-2, artificial intelligence, antigen (Ag)

العلاقة: https://figshare.com/articles/presentation/Presentation_1_Experimental_validation_of_immunogenic_SARS-CoV-2_T_cell_epitopes_identified_by_artificial_intelligence_pdf/25258327Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.1265044.s001Test
https://figshare.com/articles/presentation/Presentation_1_Experimental_validation_of_immunogenic_SARS-CoV-2_T_cell_epitopes_identified_by_artificial_intelligence_pdf/25258327Test

المؤلفون: V. V. Rassokhin, A. V. Nekrasova, В. В. Рассохин, А. В. Некрасова

المصدر: HIV Infection and Immunosuppressive Disorders; Том 16, № 1 (2024); 7-22 ; ВИЧ-инфекция и иммуносупрессии; Том 16, № 1 (2024); 7-22 ; 2077-9828 ; 10.22328/2077-9828-2024-16-1

مصطلحات موضوعية: синдром восстановления иммунной системы, Hodgkin’s lymphoma, HIV-HL, pathogenesis, clinical features, antiretroviral therapy, CD4 lymphocytes, opportunistic infections, immune reconstitution inflammatory syndrome (IRIS), лимфома Ходжкина, ВИЧ-ЛХ, патогенез, клинические особенности, антиретровирусная терапия, CD4-лимфоциты, оппортунистические инфекции

وصف الملف: application/pdf

العلاقة: https://hiv.bmoc-spb.ru/jour/article/view/877/575Test; Ладная Н.Н., Покровский В.В., Соколова Е.В. Эпидемическая ситуация по ВИЧ-инфекции в Российской Федерации в 2022 г. // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2023. Т. 3. С. 13–19. doi: https://dx.doi.org/10.18565/epidem.2023.13.3.13-9Test.; https://www.who.int/ru/news-room/fact-sheets/detail/hiv-aidsTest.; Каприн А.Д., Воронин Е.Е., Рассохин В.В., Розенберг В.Я. и др. Злокачественные новообразования, ассоциированные с ВИЧ-инфекцией. Проблемы и пути решения (проблемный очерк) // Современная онкология. 2021. Т. 23, № 3. С. 502–507. doi:10.26442/18151434.2021.3.201041.; Пивник А.В., Вукович А.М., Кремнева Н.В. и др. Лимфома Ходжкина у ВИЧ-инфицированных пациентов // Клин. онкогематология. 2021. Т. 14, № 1. С. 63–68. doi:10.21320/2500-2139-2021-14-1-63-68.; Carbone A., Vaccher E., Gloghini A. Hematologic cancers in individuals infected by HIV // Blood. 2022. Vol. 139, No. 7. Р. 995–1012. doi:10.1182/blood.2020005469.; Engels E.A., Pfeiffer R.M., Goedert J.J. et al. Trends in cancer risk among people with AIDS in the United States 1980–2002 // AIDS. 2006. Vol. 20. Р. 1645–1654. doi:10.1097/01.aids.0000238411.75324.59.; Engels E.A., Biggar R.J., Hall H.I. et al. Cancer risk in people infected with human immunodeficiency virus in the United States // Int. J. Cancer. 2008. Vol. 123. Р. 187–194. doi:10.1002/ijc.23487.; Patel P., Hanson D.L., Sullivan P.S. et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003 // Ann. Intern Med. 2008. Vol. 148. Р. 728–736. doi:10.7326/0003-4819-148-10-200805200-00005.; Hernandez-Ramirez R.U., Shiels M.S., Dubrow R., Engels E.A. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population based, registry-linkage study // Lancet HIV. 2017. Vol. 4. e495–e504. doi:10.1016/S2352-3018(17)30125-X.; Robbins H.A., Shiels M.S., Pfeiffer R.M., Engels E.A. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States // AIDS. 2014. Vol. 28. Р. 881–890. doi:10.1097/QAD.0000000000000163.; Berhan A., Bayleyegn B., Getaneh Z. HIV/AIDS Associated Lymphoma: Review // Blood Lymphat Cancer. 2022. Apr 29. Vol. 12. Р. 31–45. doi:10.2147/BLCTT.S361320.; Hernández-Walias F.J., Vázquez E., Pacheco Y., Rodríguez-Fernández J.M. et al. Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21 // Journal of Clinical Medicine. 2020, Vol. 9, No. 3. Р. 760. doi:10.3390/jcm9030760.; Чекалов А.М., Попова М.О., Цыганков И.В., Рогачева Ю.А. и др. Эпидемиология и результаты терапии первой линии ВИЧ-ассоциированной лимфомы Ходжкина // Ученые записки ПСПбГМУ им. акад. И. П. Павлова. 2022. Т. 29, № 3. С. 65–73. doi:10.24884/1607-4181-2022-29-3-65-73.; Ruiz M., Parsons C., Cole J. Characterization of HIV-associated Hodgkin’s lymphoma in HIV-infected patients: a single-center experience // J. Int. Assoc. Physicians AIDS Care (Chic). 2012. Vol. 11. Р. 234–238. doi:10.1177/1545109711431492.; Sorigue M., Garcia O., Tapia G. et al. HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma. AIDS. 2017. Vol. 31. Р. 1445–1449. doi:10.1097/QAD.0000000000001487.; Diez-Martin J.L., Balsalobre P., Re A. et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation // Blood. 2009. Vol. 113. Р. 6011–6014. doi:10.1182/blood-2008-12-195388.; Carbone A., Gloghini A., Serraino D., Spina M., Tirelli U., Vaccher E. Immunodeficiency-associated Hodgkin lymphoma // Expert Review of Hematology. 2021. Vol. 14, No. 6. Р. 547–559. doi:10.1080/17474086.2021.1935851.; Verdu-Bou М., Tapia G., Hernandez-Rodriguez A., Navarro J.-T. Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas // Cancers. 2021. Vol. 13, No. 21. Р. 5534. doi:10.3390/cancers13215534.; Caccuri F., Messali S., Zani A., Campisi G. et al. HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide // Proc. Natl. Acad. Sci. USA. 2022. Jul 5. Vol. 119, No. 27. e2122050119. doi:10.1073/pnas.2122050119.; Carbone A., Gloghini A., Caruso A., De Paoli P., Dolcetti R. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis // Int. J. Cancer. 2017. Vol. 140. Р. 1233–1245. https://doi.org/10.1002/ijc.30473Test.; Lang F., Pei Y., Lamplugh Z.L., Robertson E.S. Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis // Meyers C. (eds) HIV/AIDS-Associated Viral Oncogenesis // Cancer Treatment and Research. 2019. Vol 177. Springer, Cham. doi:10.1007/978-3-030-03502-0_4.; Dandachi D., Morón F. Effects of HIV on the Tumor Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironment // Advances in Experimental Medicine and Biology. 2020. Vol. 1263. Springer, Cham. doi:10.1007/978-3-030-44518-8_4.; Navarro J.-T., Moltó J., Tapia G., Ribera J.-M. Hodgkin Lymphoma in People Living with HIV // Cancers. 2021. Vol. 13, No. 17. Р. 4366. doi:10.3390/cancers13174366.; Biggar R.J., Jaffe E.S., Goedert J.J. et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS // Blood. 2006. Vol. 108. Р. 3786–3791. doi:10.1182/blood-2006-05-024109.; Ruperto L.R. et al. Autoimmunity and HIV infection // Translational Autoimmunity. Vol. 3, Ch. 7. Р. 141–167. https://doi.org/10.1016/B978-0-323-85415-3.00015-5Test.; Беляков Н.А., Трофимова Т.Н., Боева Е.В., Семенова М.Д. Современное звучание проблемы синдрома восстановления иммунитета на фоне АРВТ // ВИЧ-инфекция и иммуносупрессии. 2018. Т. 10, № 2. С. 14–27. https://doi.org/10.22328/2077-9828-2018-10-2-14-27Test.; Bohlius J., Schmidlin K., Boué F., Fätkenheuer G., May M., Caro-Murillo A.M., Mocroft A., Bonnet F., Clifford G., Paparizos V. et al. HIV-1- Related Hodgkin Lymphoma in the Era of Combination Antiretroviral Therapy: Incidence and Evolution of CD4+ T-Cell Lymphocytes // Blood. 2011. Vol. 117. Р. 6100–6108. doi:10.1182/blood-2010-08-301531.; Re A., Cattaneo C., Rossi G. HIV and Lymphoma: From Epidemiology to Clinical Management. Mediterr // J. Hematol. Infect. Dis. 2019. Vol. 11. e2019004. doi:10.4084/MJHID.2019.004.; Carbone A., Gloghini A. HIV-Associated Lymphoid Disorders // Molina T.J. (eds) Hematopathology. Encyclopedia of Pathology. Springer, Cham, 2020. doi:10.1007/978-3-319-95309-0_3840.; Kimani S.M., Painschab M.S., Horner M.-J., Muchengeti M., Fedoriw Y., Shiels M.S., Gopal S. Epidemiology of Haematological Malignancies in People Living with HIV // Lancet HIV. 2020. Vol. 7. e641–e651. doi:10.1016/S2352-3018(20)30118-1.; Kowalkowski M.A., Mims M.P., Amiran E.S., Lulla P., Chiao E.Y. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma // PLoS One. 2013 Oct 2. Vol. 8, No. 10. е77409. doi:10.1371/journal.pone.0077409.; Kowalkowski M.A., Mims M.A., Day R.S., Du X.L., Chan W., Chiao E.Y. Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans // Cancer Epidemiol. 2014. Aug. Vol. 38, No. 4. Р. 386–392. doi:10.1016/j.canep.2014.05.009.; Choe P.G., Park J., Park W.B., Kim T.M. et al. Immune reconstitution inflammatory syndrome versus non-immune reconstitution inflammatory syndrome lymphoma in HIV patients on antiretroviral therapy // Int. J. STD AIDS. 2016 Oct. Vol. 27, No. 11. Р. 1013–1015. doi:10.1177/0956462416630908.; Gopal S., Patel M.R., Achenbach C.J., Yanik E.L. et al. Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort // Clin. Infect Dis. 2014. Jul 15. Vol. 59, No. 2. Р. 279–286. doi:10.1093/cid/ciu270.; Mani H., Jaffe E.S. Hodgkin lymphoma: an update on its biology with new insights into classification // Clin. Lymphoma Myeloma. 2009. Vol. 9. Р. 206–216. doi:10.3816/CLM.2009.n.042.; NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cancer in People with HIV. Version 1. 2024. November 7, 2023.; Besson C., Lancar R., Prevot S. et al. High risk features contrast with favorable outcomes in HIV-associated Hodgkin lymphoma in the modern cART era, ANRS CO16 LYMPHOVIR cohort // Clin. Infect Dis 2015. Vol. 61. Р. 1469–1475. doi:10.1093/cid/civ627.; Shah B.K., Subramaniam S., Peace D., Garcia C. HIV-associated primary bone marrow Hodgkin’s lymphoma: a distinct entity? // J. Clin. Oncol. 2010. Vol. 28. Р. 459–460. doi:10.1200/JCO.2010.28.3077.; O’Neill A., Mikesch K., Fritsch K. et al. Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT // Bone Marrow Transplant. 2015. Vol. 50. Р. 999–1000. doi:10.1038/bmt.2015.18.; Glaser S.L., Clarke C.A., Gulley M.L. et al. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998 // Cancer. 2003. Vol. 98. Р. 300–309. doi:10.1002/cncr.11459.; Montoto S., Shaw K., Okosun J. et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era // J. Clin. Oncol. 2012. Vol. 30. Р. 4111–4116. doi:10.1200/JCO.2011.41.4193.; Shiels M.S., Koritzinsky E.H., Clarke C.A. et al. Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases // Cancer Epidemiol Biomarkers Prev. 2014. Vol. 23. Р. 274–281. doi:10.1158/1055-9965.EPI-13-0865.; Hessol N.A., Pipkin S., Schwarcz S. et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS // Am. J. Epidemiol. 2007. Vol. 165. Р. 1143–1153. doi:10.1093/aje/kwm017.; Hoffmann C., Chow K.U., Wolf E. et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin’s disease // Br. J. Haematol. 2004. Vol. 125. Р. 455–462. doi:10.1111/j.1365-2141.2004.04934.x.; Демина Е.А., Тумян Г.С., Моисеева Т.Н., Михайлова Н.Б. и др. Лимфома Ходжкина. Клинические рекомендации // Современная онкология. 2020. Т. 22, № 2. С. 6–33. doi:10.26442/18151434.2020.2.200132 (In Russ.); Клинические рекомендации «ВИЧ-инфекция у взрослых». МЗ РФ. М., 2020.; Демина Е.А. Руководство по лечению лимфомы Ходжкина. 2-е изд., доп. М.: изд-во ООО «Рекламное агентство «Ре Медиа», 2021. 96 с.: ил.; Аббасбейли Ф.М., Феденко А.А., Зейналова П.А. и др. Клинические возможности проточной цитометрии при лимфоме Ходжкина // Онкогематология. 2023. Т. 18, № 3. С. 70–77. doi:10.17650/1818-8346-2023-18-3-70-77; Coghill A.E., Shiels M.S., Suneja G., Engels E.A. Elevated cancerspecific mortality among HIV-infected patients in the United States // J. Clin. Oncol. 2015. Vol. 33. Р. 2376–2383. doi:10.1200/JCO.2014.59.5967.; Marcus J.L., Chao C., Leyden W.A. et al. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers // Cancer Epidemiol Biomarkers Prev. 2015. Vol. 24. Р. 1167–1173. doi:10.1158/1055-9965.EPI-14-1079.; Suneja G., Lin C.C., Simard E.P. et al. Disparities in cancer treatment among patients infected with the human immunodeficiency virus // Cancer. 2016. Vol. 122. Р. 2399–2407. doi:10.1002/cncr.30052.; Olszewski A.J., Castillo J.J. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy // AIDS. 2016. Vol. 30. Р. 787– 796. doi:10.1097/QAD.0000000000000986.; Han X., Jemal A., Hulland E. et al. HIV infection and survival of lymphoma patients in the era of highly active antiretroviral therapy // Cancer Epidemiol Biomarkers Prev. 2017. Vol. 26. Р. 303–311. doi:10.1158/1055-9965.EPI-16-0595.; Xicoy B., Ribera J.M., Miralles P. et al. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin’s lymphoma // Haematologica. 2007. Vol. 92. Р. 191–198. doi:10.3324/haematol.10479.; Spina M., Gabarre J., Rossi G. et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection // Blood. 2002. Vol. 100. Р. 1984–1988. doi:10.1182/blood-2002-03-0989.; Hartmann P., Rehwald U., Salzberger B. et al. BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection // Ann. Oncol. 2003. Vol. 14. Р. 1562–1569. doi:10.1093/annonc/mdg408.; Hentrich M., Berger M., Wyen C. et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study // J. Clin. Oncol. 2012. Vol. 30. Р. 4117–4123. doi:10.1200/JCO.2012.41.8137.; Rubinstein P.G., Moore P.C., Bimali M. et al. Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial // Lancet Haematol. 2023. Vol. 10. Р. е624–e632. doi:10.1016/S2352-3026(23)00157-6.; Ковальская В.Ю., Фалалеева Н.А., Терехова А.Ю., Даниленко А.А., Богатырева Т.И. Опыт лечения лимфомы Ходжкина, протекающей на фоне ВИЧ // Российский журнал персонализированной медицины. 2023. Vol. 3, No. 5. Р. 60–73. EDN: BBVLLV. doi:10.18705/2782-3806-2023-3-5-60-73.; Ezzat H.M., Cheung M.C., Hicks L.K. et al. Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma // Leuk. Lymphoma. 2012. Vol. 53. Р. 2390–2396. doi:10.3109/10428194.2012.697560.; Rubinstein P.G., Moore P.C., Rudek M.A. et al. Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma // AIDS. 2018. Vol. 32. Р. 605–611. doi:10.1097/QAD.0000000000001729.; Spitzer T.R., Ambinder R.F., Lee J.Y. et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020 // Biol. Blood Marrow Transplant. 2008. Vol. 14. Р. 59–66. doi:10.1016/j.bbmt.2007.03.014.; Balsalobre P., Diez-Martin J.L., Re A. et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma // J. Clin. Oncol. 2009. Vol. 27. Р. 2192–2198. doi:10.1200/JCO.2008.18.2683.; Alvarnas J.C., Le Rademacher J., Wang Y. et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial // Blood. 2016. Vol. 128. Р. 1050–1058. doi:10.1182/blood-2015-08-664706.; Ambinder R.F., Wu J., Logan B. et al. Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: The BMT CTN0903/AMC-080 Trial // Biol. Blood Marrow Transplant. 2019. Vol. 25. Р. 2160–2166. Available at: https://doi.org/10.1016/j.bbmt.2019.06.033Test.; Okosun J., Warbey V., Shaw K. et al. Interim fluoro-2-deoxy-Dglucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection // AIDS. 2012. Vol. 26. Р. 861–865. doi:10.1097/QAD.0b013e32835213b1.; Danilov A.V., Li H., Press O.W. et al. Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial // Leuk. Lymphoma. 2017. Vol. 58. Р. 461–465. doi:10.1080/10428194.2016.1201573.; Cheson B.D., Pfistner B., Juweid M.E., Gascoyne R.D. et al. International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma // J. Clin. Oncol. 2007. Feb 10. Vol. 25, No. 5. Р. 579–586. doi:10.1200/JCO.2006.09.2403; https://hiv.bmoc-spb.ru/jour/article/view/877Test

الإتاحة: https://doi.org/10.22328/2077-9828-2024-16-1-7-22Test
https://doi.org/10.22328/2077-9828-2024-16-1Test
https://doi.org/10.18565/epidem.2023.13.3.13-9Test
https://doi.org/10.26442/18151434.2021.3.201041Test
https://doi.org/10.21320/2500-2139-2021-14-1-63-68Test
https://doi.org/10.1182/blood.2020005469Test
https://doi.org/10.1097/01.aids.0000238411.75324.59Test
https://doi.org/10.1002/ijc.23487Test
https://doi.org/10.7326/0003-4819-148-10-200805200-00005Test
https://doi.org/10.1016/S2352-3018Test(17)30125-X

المؤلفون: Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff, Richard Stratford, Trevor Clancy, Ludvig Andre Munthe

المصدر: Frontiers in Immunology, Vol 14 (2023)

مصطلحات موضوعية: T cell, COVID-19, CD8+ lymphocytes, CD4+ lymphocytes, vaccine, SARS-CoV-2, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1265044/fullTest; https://doaj.org/toc/1664-3224Test

الوصول الحر: https://doaj.org/article/196a2fd0f4914004b3f5f63d54028800Test

المؤلفون: Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff, Richard Stratford, Trevor Clancy, Ludvig Andre Munthe

مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, T cell, COVID-19, CD8+ lymphocytes, CD4+ lymphocytes, vaccine, SARS-CoV-2, artificial intelligence, antigen (Ag)

العلاقة: https://figshare.com/articles/presentation/Presentation_1_Experimental_validation_of_immunogenic_SARS-CoV-2_T_cell_epitopes_identified_by_artificial_intelligence_pdf/24580042Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.1265044.s001Test
https://figshare.com/articles/presentation/Presentation_1_Experimental_validation_of_immunogenic_SARS-CoV-2_T_cell_epitopes_identified_by_artificial_intelligence_pdf/24580042Test

المؤلفون: Mircea Bajdechi, Adriana Gurghean, Vlad Bataila, Alexandru Scafa-Udriște, Georgiana-Elena Bajdechi, Roxana Radoi, Anca Cristiana Oprea, Valentin Chioncel, Iuliana Mateescu, Lucia Zekra, Roxana Cernat, Irina Magdalena Dumitru, Sorin Rugina

المصدر: Diagnostics, Vol 13, Iss 16, p 2682 (2023)

مصطلحات موضوعية: atherosclerosis, acute coronary syndrome, HIV, chronic inflammation, CD4+ lymphocytes, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2075-4418/13/16/2682Test; https://doaj.org/toc/2075-4418Test

الوصول الحر: https://doaj.org/article/710f3b54fac8442586fbd301ed2a3e19Test

المؤلفون: Yuntao Feng, Xuebo Liu, Hongwei Tan

المصدر: Frontiers in Cardiovascular Medicine, Vol 9 (2023)

مصطلحات موضوعية: peripheral immunity, atrial fibrillation, Mendelian randomization, CD4 + lymphocytes, causation analysis, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042938/fullTest; https://doaj.org/toc/2297-055XTest

الوصول الحر: https://doaj.org/article/e028952ce0bc41a2b72078896281608aTest

المؤلفون: Gao, Keming, Kaye, Nicholas M., Ayati, Marzieh, Koyuturk, Mehmet, Calabrese, Joseph R., Christian, Eric, Lazarus, Hillard M., Kaplan, David

المصدر: Computer Science Faculty Publications and Presentations

مصطلحات موضوعية: lithium treatment, bipolar disorder, monocytes and CD4+ lymphocytes, biomarkers, intracellular proteins, Computer Sciences, Medicine and Health Sciences

وصف الملف: application/pdf

العلاقة: https://scholarworks.utrgv.edu/cs_fac/112Test; https://scholarworks.utrgv.edu/context/cs_fac/article/1111/viewcontent/pdf.pdfTest

الإتاحة: https://doi.org/10.3390/medicina59010120Test
https://scholarworks.utrgv.edu/cs_fac/112Test
https://scholarworks.utrgv.edu/context/cs_fac/article/1111/viewcontent/pdf.pdfTest

المؤلفون: Keming Gao, Nicholas M. Kaye, Marzieh Ayati, Mehmet Koyuturk, Joseph R. Calabrese, Eric Christian, Hillard M. Lazarus, David Kaplan

المصدر: Medicina; Volume 59; Issue 1; Pages: 120

مصطلحات موضوعية: lithium treatment, bipolar disorder, monocytes and CD4 + lymphocytes, biomarkers, intracellular proteins

وصف الملف: application/pdf

العلاقة: Psychiatry; https://dx.doi.org/10.3390/medicina59010120Test

الإتاحة: https://doi.org/10.3390/medicina59010120Test